GFC Life Science Co., Ltd (KOSDAQ:388610)
5,760.00
+120.00 (2.13%)
At close: Sep 28, 2026
| Market Cap | 30.32B -72.5% |
| Revenue (ttm) | 19.24B +12.3% |
| Net Income | 1.08B -69.5% |
| EPS | 204.54 -77.7% |
| Shares Out | 5.26M |
| PE Ratio | 28.16 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 6,444 |
| Open | 5,640.00 |
| Previous Close | 5,640.00 |
| Day's Range | 5,560.00 - 5,830.00 |
| 52-Week Range | 4,460.00 - 22,400.00 |
| Beta | 0.71 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Sep 29, 2026 |